Boston, MA
Summary
This Boston-based therapeutics company utilizes advanced artificial intelligence, physics-based tools, and automation to discover novel small molecules aimed at difficult targets. The company is currently advancing its lead asset through IND-enabling studies and is focused on developing treatments for inflammatory and immune diseases, including multiple autoimmune conditions.
Link